Science and Technology Committee
14 April 2026
No chapters available yet
Legend
Transcript markers
- text Sentence being played
- text Search result
- text Intervention cited by the link you opened
Click a sentence to play the video from that moment. Select text to quote it with the speaker, timestamp and link.
More options
Committee House of Lords
00:00 - 01:08
Speaker 1
Good morning. Welcome to the Science and Technology Select Committee. We're undertaking an inquiry on innovation in the NHS, personalized medicines, and AI, We're very pleased to have as our first witness this morning Professor Andrew Morris, who's Director of Health Data Research UK and he's President of the Academy of Medical Sciences. Professor Morris, I would like to start. Can you perhaps set out for our committee what Health Data Research UK does and how it fits into the wider health data landscape?
And and what, in your view, it has achieved since you became its inaugural director in 2017? And perhaps, also, can you say what is the current state of The UK's health data infrastructure? What works and what does not work, and and where the most significant gaps are in your view? So over to you, professor Morris.
01:09 - 02:37
Speaker 2
Thank you, lord mayor, and just say it's a real privilege to be here today. So I'm Andrew Morris. I'm a doctor. I'm professor of medicine at the University of Edinburgh and vice principal there, but I'm seconded to London to do two jobs. One is to be director of Health Data Research UK, which is the National Institute for Health Data Science, and I also have the privilege of being president of the Academy of Medical Sciences, which is one of the four national academies in The UK.
K. I should say, just to frame this, I fell into data about thirty five years ago. Actually, I was working with Lord Patel in Dundee, I was a diabetes doctor and I realized that by working with colleagues, especially general practitioners, that by following journeys of care of individual patients across primary, secondary, tertiary and social care and joining up that journey with data, it was not only good to improve care, we reduced amputations, Lord Patel will remember, by fifty percent in four years and blindness by forty percent. But one could use the same data to drive public health, clinical trials, research and innovation, and genetic studies. So data has infrastructure across a population, and that has endured.
The rest of the transcript is for Pro customers
Unlock the full transcript, chat, and every analysis feature with Polyfact Pro.
Ask anything about this video — I analyse its transcript to answer.